Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Allovir Inc

Current price
0.75 USD +0.0002 USD (+0.03%)
Last closed 0.74 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 88 093 040 USD
Yield for 12 month -80.15 %
21.11.2021 - 28.11.2021

Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Its preclinical and clinical development product candidates include ALVR106 for the respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109 to treat SARS-CoV-2 and COVID-19; ALVR107 for treating hepatitis B; and ALVR108. The company was formerly known as ViraCyte, Inc. and changed its name to Allovir, Inc. in May 2019. The company was incorporated in 2013 and is based in Waltham, Massachusetts. Address: 1100 Winter Street, Waltham, MA, United States, 02451

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price


P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-398 000 USD

Last Year

-2 565 000 USD

Current Quarter

-141 000 USD

Last Quarter

-3 643 000 USD

Key Figures ALVR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -180 932 992 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -48.44 %
PEG Ratio
Return On Equity TTM -102.85 %
Wall Street Target Price 1 USD
Revenue TTM
Book Value 1.32 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM 165 000 USD
Earnings Share -1.83 USD
Diluted Eps TTM -1.83 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ALVR

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ALVR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ALVR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 0.3782
Price Book MRQ 0.6043

Financials ALVR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ALVR

For 52 weeks

0.62 USD 6.12 USD
50 Day MA 0.73 USD
Shares Short Prior Month 6 272 836
200 Day MA 1.78 USD
Short Ratio 12.99
Shares Short 6 304 402
Short Percent 9.7 %

Dynamics of changes in the value of assets




399.12 USD Microsoft Corporation -4.91 (-1.22%)
Detailed analytics

ETF funds



207.85 CHF iShares MDAX UCITS ETF (DE) 0 (0%)
Detailed analytics



2175.88 USD Gold +5.94 (+0.27%)
Detailed analytics